Home
>
National Drug Code (NDC)
>
Levetiracetam
Levetiracetam - 0591-3635-05 - (Levetiracetam)
Drug Information of Levetiracetam
| Product NDC: | 0591-3635 |
| Proprietary Name: | Levetiracetam |
| Non Proprietary Name: | Levetiracetam |
| Active Ingredient(s): | 500 mg/1 & nbsp; Levetiracetam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Levetiracetam
| Product NDC: | 0591-3635 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091093 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110912 |
Package Information of Levetiracetam
| Package NDC: | 0591-3635-05 |
| Package Description: | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3635-05) |
NDC Information of Levetiracetam
| NDC Code | 0591-3635-05 |
| Proprietary Name | Levetiracetam |
| Package Description | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3635-05) |
| Product NDC | 0591-3635 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levetiracetam |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20110912 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | LEVETIRACETAM |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
